Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose
收藏官方服务：
资源简介：
To evaluate the humoral response of SARS-CoV-2 variants in patients with IBD 60 days after receiving the third dose of mRNA COVID-19 vaccine.
提供机构：
ImmPort创建时间：
2024-10-18
